BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 10326425)

  • 1. Fluid and electrolyte management of ascites in patients with cirrhosis.
    Bass M
    Crit Care Nurs Clin North Am; 1998 Dec; 10(4):459-67. PubMed ID: 10326425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ascites. A review.
    Watanabe A
    J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with cirrhosis and ascites.
    Runyon BA
    Semin Liver Dis; 1997; 17(3):249-60. PubMed ID: 9308129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC; Vaillant JC; Breton S; Hannoun L
    Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cirrhotic ascites.
    Alaniz C
    Clin Pharm; 1989 Sep; 8(9):645-54. PubMed ID: 2676316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
    Ainsworth MA; Nielsen OH
    Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of adult patients with ascites caused by cirrhosis.
    Runyon BA
    Hepatology; 1998 Jan; 27(1):264-72. PubMed ID: 9425946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiologic basis for the treatment of cirrhotic ascites.
    Wong F; Blendis L
    Clin Liver Dis; 2001 Aug; 5(3):819-32. PubMed ID: 11565142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
    Aalykke C; Tønner-Nielsen D; Vilstrup H
    Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Uriz J; Cárdenas A; Arroyo V
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):927-43. PubMed ID: 11139347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
    Neong SF; Adebayo D; Wong F
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.